Journal Article
R. Salerno-Gonçalves, Chen, W. H., Mulligan, M. J., Frey, S. E., Stapleton, J. T., Keitel, W. A., Bailey, J., Sendra, E., Hill, H., Johnson, R. A., and Sztein, M. B.,
“Vaccine-related major cutaneous reaction size correlates with cellular-mediated immune responses after tularaemia immunisation.”,
Clin Transl Immunology, vol. 10, no. 1, p. e1239, 2021.
M. J. Mulligan, Stapleton, J. T., Keitel, W. A., Frey, S. E., Chen, W. H., Rouphael, N., Edupuganti, S., Beck, A., Winokur, P. L., Sahly, H. M. El, Patel, S. M., Atmar, R. L., Graham, I., Anderson, E., El-Kamary, S. S., Pasetti, M. F., Sztein, M. B., Hill, H., and Goll, J. B.,
“Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.”,
Vaccine, vol. 35, no. 36, pp. 4730-4737, 2017.
F. K. Newman, Frey, S. E., Blevins, T. P., Yan, L., and Belshe, R. B.,
“Stability of undiluted and diluted vaccinia-virus vaccine, Dryvax.”,
J Infect Dis, vol. 187, no. 8, pp. 1319-22, 2003.
J. D. Troy, Hill, H. R., Ewell, M. G., and Frey, S. E.,
“Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine.”,
Vaccine, vol. 33, no. 41, pp. 5425-5431, 2015.
F. M. Munoz, Patel, S. M., Jackson, L. A., Swamy, G. K., Edwards, K. M., Frey, S. E., Petrie, C. R., Sendra, E. A., and Keitel, W. A.,
“Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants.”,
Vaccine, vol. 38, no. 33, pp. 5355-5363, 2020.
F. M. Munoz, Jackson, L. A., Swamy, G. K., Edwards, K. M., Frey, S. E., Stephens, I., Ault, K., Winokur, P., Petrie, C. R., Wolff, M., Patel, S. M., and Keitel, W. A.,
“Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.”,
Vaccine, vol. 36, no. 52, pp. 8054-8061, 2018.
R. B. Belshe, Frey, S. E., Graham, I., Mulligan, M. J., Edupuganti, S., Jackson, L. A., Wald, A., Poland, G., Jacobson, R., Keyserling, H. L., Spearman, P., Hill, H., and Wolff, M.,
“Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant.”,
J Infect Dis, vol. 203, no. 5, pp. 666-73, 2011.
S. E. Frey, Houghton, M., Coates, S., Abrignani, S., Chien, D., Rosa, D., Pileri, P., Ray, R., Di Bisceglie, A. M., Rinella, P., Hill, H., Wolff, M. C., Schultze, V., Han, J. H., Scharschmidt, B., and Belshe, R. B.,
“Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.”,
Vaccine, vol. 28, no. 38, pp. 6367-73, 2010.
L. A. Jackson, Frey, S. E., Sahly, H. M. El, Mulligan, M. J., Winokur, P. L., Kotloff, K. L., Campbell, J. D., Atmar, R. L., Graham, I., Anderson, E. J., Anderson, E. L., Patel, S. M., Fields, C., Keitel, W., Rouphael, N., Hill, H., and Goll, J. B.,
“Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial.”,
Vaccine, vol. 35, no. 13, pp. 1675-1682, 2017.
S. L. George, Wong, M. A., Dube, T. J. T., Boroughs, K. L., Stovall, J. L., Luy, B. E., Haller, A. A., Osorio, J. E., Eggemeyer, L. M., Irby-Moore, S., Frey, S. E., Huang, C. Y. - H., and Stinchcomb, D. T.,
“Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial.”,
J Infect Dis, vol. 212, no. 7, pp. 1032-41, 2015.
S. E. Frey, Bernstein, D. I., Gerber, M. A., Keyserling, H. L., Munoz, F. M., Winokur, P. L., Turley, C. B., Rupp, R. E., Hill, H., Wolff, M., Noah, D. L., Ross, A. C., Cress, G., and Belshe, R. B.,
“Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.”,
J Infect Dis, vol. 206, no. 6, pp. 828-37, 2012.
R. C. Brady, Jackson, L. A., Frey, S. E., Shane, A. L., Walter, E. B., Swamy, G. K., Schlaudecker, E. P., Szefer, E., Wolff, M., McNeal, M. Malone, Bernstein, D. I., and Steinhoff, M. C.,
“Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women.”,
Vaccine, vol. 36, no. 31, pp. 4663-4671, 2018.
D. F. Hoft, Lottenbach, K., Goll, J. B., Hill, H., Winokur, P. L., Patel, S. M., Brady, R. C., Chen, W. H., Edwards, K., C Creech, B., Frey, S. E., Blevins, T. P., Salomon, R., and Belshe, R. B.,
“Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.”,
J Infect Dis, vol. 214, no. 7, pp. 1020-9, 2016.
S. E. Frey, Bernstein, D. I., Brady, R. C., Keitel, W. A., Sahly, H. El, Rouphael, N. Georges, Mulligan, M. J., Atmar, R. L., Edupuganti, S., Patel, S. M., Dickey, M., Graham, I., Anderson, E. L., Noah, D. L., Hill, H., Wolff, M., and Belshe, R. B.,
“Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.”,
Vaccine, vol. 33, no. 1, pp. 163-73, 2015.
S. E. Frey, Winokur, P. L., Hill, H., Goll, J. B., Chaplin, P., and Belshe, R. B.,
“Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals.”,
Vaccine, vol. 32, no. 23, pp. 2732-9, 2014.
J. J. Treanor, Atmar, R. L., Frey, S. E., Gormley, R., Chen, W. H., Ferreira, J., Goodwin, R., Borkowski, A., Clemens, R., and Mendelman, P. M.,
“A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults.”,
J Infect Dis, vol. 210, no. 11, pp. 1763-71, 2014.
K. L. Kotloff, Shirley, D. - A. T., C Creech, B., Frey, S. E., Harrison, C. J., Staat, M., Anderson, E. J., Dulkerian, S., Thomsen, I. P., Al-Hosni, M., Pahud, B. A., Bernstein, D. I., Yi, J., Petrikin, J. E., Haberman, B., Stephens, K., Stephens, I., Oler, R. E., and Conrad, T. M.,
“Mupirocin for Decolonization of Infants in Neonatal Intensive Care Units.”,
Pediatrics, vol. 143, no. 1, 2019.
J. S. Kennedy, Frey, S. E., Yan, L., Rothman, A. L., Cruz, J., Newman, F. K., Orphin, L., Belshe, R. B., and Ennis, F. A.,
“Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.”,
J Infect Dis, vol. 190, no. 7, pp. 1286-94, 2004.
R. B. Belshe, Frey, S. E., Graham, I. L., Anderson, E. L., Jackson, L. A., Spearman, P., Edupuganti, S., Mulligan, M. J., Rouphael, N., Winokur, P., Dolor, R. J., Woods, C. W., Walter, E. B., Chen, W. H., Turley, C., Edwards, K. M., C Creech, B., Hill, H., and Bellamy, A. R.,
“Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.”,
JAMA, vol. 312, no. 14, pp. 1420-8, 2014.
L. A. Jackson, Patel, S. M., Swamy, G. K., Frey, S. E., C Creech, B., Munoz, F. M., Artal, R., Keitel, W. A., Noah, D. L., Petrie, C. Rodeheffer, Wolff, M., and Edwards, K. M.,
“Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women.”,
J Infect Dis, vol. 204, no. 6, pp. 854-63, 2011.
P. Winokur, Sahly, H. M. El, Mulligan, M. J., Frey, S. E., Rupp, R., Anderson, E. J., Edwards, K. M., Bernstein, D. I., Schmader, K., Jackson, L. A., Chen, W. H., Hill, H., and Bellamy, A.,
“Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.”,
Vaccine, vol. S0264-410X, no. 20, pp. 31504-31508, 2021.
S. E. Frey, Stapleton, J. T., Ballas, Z. K., Rasmussen, W. L., Kaufman, T. M., Blevins, T., Jensen, T. L., D Davies, H., Tary-Lehman, M., Chaplin, P., Hill, H., and Goll, J. B.,
“Human antibody responses following vaccinia immunization using protein microarrays and correlation with cell-mediated and antibody dependent cellular cytotoxicity responses.”,
J Infect Dis, 2021.
L. A. Jackson, Campbell, J. D., Frey, S. E., Edwards, K. M., Keitel, W. A., Kotloff, K. L., Berry, A. A., Graham, I., Atmar, R. L., C Creech, B., Thomsen, I. P., Patel, S. M., Gutierrez, A. F., Anderson, E. L., Sahly, H. M. El, Hill, H., Noah, D. L., and Bellamy, A. R.,
“Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.”,
JAMA, vol. 314, no. 3, pp. 237-46, 2015.
R. B. Belshe, Newman, F. K., Frey, S. E., Couch, R. B., Treanor, J. J., Tacket, C. O., and Yan, L.,
“Dose-dependent neutralizing-antibody responses to vaccinia.”,
J Infect Dis, vol. 189, no. 3, pp. 493-7, 2004.
S. E. Frey, Wald, A., Edupuganti, S., Jackson, L. A., Stapleton, J. T., Sahly, H. El, El-Kamary, S. S., Edwards, K., Keyserling, H., Winokur, P., Keitel, W., Hill, H., Goll, J. B., Anderson, E. L., Graham, I. L., Johnston, C., Mulligan, M., Rouphael, N., Atmar, R., Patel, S., Chen, W., Kotloff, K., C Creech, B., Chaplin, P., and Belshe, R. B.,
“Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.”,
Vaccine, vol. 33, no. 39, pp. 5225-34, 2015.
]